Annual Drug Patent Expirations for TYMLOS
Tymlos is a drug marketed by Radius and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for TYMLOS.
This drug has forty-six patent family members in twenty-eight countries.
The generic ingredient in TYMLOS is abaloparatide. One supplier is listed for this compound. Additional details are available on the abaloparatide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
